A prospective, randomized, double blind, single ascending dose study of SAR-425899 in healthy subjects
Latest Information Update: 22 Sep 2016
At a glance
- Drugs SAR 425899 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Acronyms SAD
- 22 Sep 2016 New trial record
- 16 Sep 2016 Results of population PK/PD model using data from SAD and MAD studies presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes